This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
SEE YOU NEXT YEAR: May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

Toru Okamatsu
Manager of Business Development at Ajinomoto Bio-Pharma Services


Toru Okamatsu is a Business Development Manager at Ajinomoto Bio-Pharma Services and has worked for Ajinomoto Co., Inc. for 15 years. Toru’s experience ranges from Medicinal Chemist, Process Development of AJIPHASE® (liquid phase oligo synthesis technology) and CMC affairs, to being responsible for solid phase based oligo project management in Aji Bio-Pharma Osaka from 2018 to 2021. Currently he focuses on oligo CDMO business development to support customers’ oligonucleotide programs with his team. Toru holds a M.S. in Organic Chemistry from Kyushu University Graduate School of Science.

Agenda Sessions

  • Go Green – Environmental Safety Approach to Oligonucleotide Manufacturing- Hall B